29.04.2010 • News

Wacker Sees Strong Sales, Earning Growth in Q1

Wacker Chemie has reported a jump in group sales for the first quarter of 2010 of 22% to €1.07 billion compared to 2009 amidst high demand. The group's Ebitda was up 61% to €254 million year over year; the net income for the quarter was reported at €106 million. The company said it expects its full-year sales to reach over €4 billion.

The company said it has boosted its profitability in both its chemical and semiconductor segments. At the three chemical segments, Ebitda of €87.0 million (Q1 2009: €51.1 million) outstripped the prior-year figure by 70%. With Ebitda of €1.2 million, Siltronic has returned to a profitable level after four quarters with losses (Q1 2009: €-60 million).

Despite lower polysilicon market prices, the company said its Polysilicon business unit succeeded in keeping its profitability very high. Its Ebitda in Q1 2010 came in at €157.5 million (Q1 2009: €168.1 million). Although 6% below the Q1 2009 record, Ebitda was well above the preceding quarters, which were affected by non-recurring items.

The company said the predicted global recovery for 2010 will further boost demand in its main sectors of interest, including chemicals, construction, electronics and photovoltaics. Wacker also said that if the world economy continues to grow as forecast, the company expects sales volumes to increase in every division during 2010.

Company

Universität Hohenheim - Institut für Lebensmitteltechnik

Garbenstrasse 25
70599 Stuttgart
Germany

Company contact







Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.